BTG plc, a public limited company is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.

PropertyValue
dbpedia-owl:Company/industry
dbpedia-owl:Company/netIncome
  • 8800000
dbpedia-owl:Company/operatingIncome
  • 8500000
dbpedia-owl:Company/product
dbpedia-owl:Organisation/foundationDate
  • 1991-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/keyPerson
dbpedia-owl:Organisation/keyPersonPosition
  • John Brown (Chairman of the board), Louise Makin (CEO)
dbpedia-owl:Organisation/location
dbpedia-owl:Organisation/numberOfEmployees
  • 284 (xsd:integer)
dbpedia-owl:Organisation/revenue
  • 75000000
dbpedia-owl:Organisation/type
dbpedia-owl:foundationDate
  • 1991-01-01 00:00:00 (xsd:date)
dbpedia-owl:industry
dbpedia-owl:keyPerson
dbpedia-owl:keyPersonPosition
  • John Brown (Chairman of the board), Louise Makin (CEO)
dbpedia-owl:location
dbpedia-owl:netIncome
  • 8800000
dbpedia-owl:numberOfEmployees
  • 284 (xsd:integer)
dbpedia-owl:operatingIncome
  • 8500000
dbpedia-owl:product
dbpedia-owl:revenue
  • 75000000
dbpedia-owl:type
dbpprop:abstract
  • BTG plc, a public limited company is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products. The company is a constituent of the FTSE 250 Index.
  • BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet.
dbpprop:companyLogo
dbpprop:companyName
  • BTG plc
dbpprop:companyType
dbpprop:foundation
  • 1991 as British Technology Group Ltd.
dbpprop:homepage
dbpprop:industry
dbpprop:intl
  • yes
dbpprop:keyPeople
dbpprop:location
dbpprop:netIncome
  • £8.8 million (yr - Mar 08)
dbpprop:numEmployees
  • 284 (xsd:integer)
dbpprop:operatingIncome
  • £8.5 million (yr - Mar 08)
dbpprop:otheruses4Property
  • Bishop Thomas Grant School
  • the British technology company
  • the school in Streatham, London
dbpprop:products
dbpprop:reference
dbpprop:revenue
  • £75.0 million (yr - Mar 2008)
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • BTG plc, a public limited company is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.
  • BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet.
rdfs:label
  • BTG
  • BTG
owl:sameAs
skos:subject
foaf:name
  • BTG plc
foaf:page
is dbpprop:redirect of